Quarterly report · Q1
2796.TEDINET S100S04W
Period2023-06-01 → 2023-08-31
Filed2023-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥348m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥312m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥318m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥123m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥111m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥127m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥114m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.2bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.11 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.88 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.93 | 2023-06-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.99 | 2022-06-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥78m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥9m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥11m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥379m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥27m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥409m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-08-31 | ¥21m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥75m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥35m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥20m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥398m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥19m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥424m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 375
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 21000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 424000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -75000000 | JPY |
| Operating income | Prior1YTDDuration | 348000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember | 10898000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | 2104000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 155000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember | 126000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 13285000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 185000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13471000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 13471000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember | 10898000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | 2104000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 155000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember | 126000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 13285000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 185000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13471000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 13471000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05379-000DispensingPharmacyReportableSegmentsMember | 379000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CosmeticDrugAndConvenienceStoreReportableSegmentsMember | -9000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05379-000CustodyOfMedicalDocumentsReportableSegmentsMember | 11000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E05379-000MedicalMallReportableSegmentsMember | 27000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 408000000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 0 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 409000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -78000000 | JPY |
| Operating income | CurrentYTDDuration | 331000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-10-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第38期第１四半期(自 令和５年６月１日 至 令和５年８月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ファーマライズホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Ｐｈａｒｍａｒｉｓｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 社長 秋 山 昌 之 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中野区中央一丁目38番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-3362-7130（代表） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |